|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Net loss | |||
| Adjustment to reconcile net loss to cash used in operating activities: | |||
| Amortization of intangible assets | |||
| Depreciation of property and equipment | |||
| Allowance for (reversal of) credit losses | |||
| Loss on disposal of intangible assets | |||
| Share-based compensations | |||
| Share of results of an associate | |||
| Loss on disposal of an associate | |||
| Impairment loss of long-term investments | |||
| Interest income from loan receivable | |||
| Lease expense | |||
| Loss on fair value change of convertible notes | |||
| Change in operating assets and liabilities: | |||
| Change in receivables from customers | |||
| Change in receivables from brokers-dealers and clearing organizations | |||
| Change in refundable deposits | |||
| Change in prepaid expenses and other current assets | |||
| Change in amount due from a director | |||
| Change in amounts with related parties | |||
| Change in payables to AI cloud service providers | |||
| Change in payables to customers | |||
| Change in contract liabilities | |||
| Change in accruals and other current liabilities | |||
| Change in right to receive cryptocurrencies | |||
| Change in income taxes payable | |||
| Change in operating lease liabilities | |||
| Cash used in operating activities | |||
| Cash flows from investing activities | |||
| Purchase of intangible assets | |||
| Purchase of property and equipment | |||
| Purchase of long-term investments, net | |||
| Acquisition of an associate | |||
| Proceeds from disposal of an associate | |||
| Acquisition of subsidiaries under common control | |||
| Repayment of loan to a third party | |||
| Cash provided by (used in) investing activities | |||
| Cash flows from financing activities | |||
| Proceeds from shareholders’ contribution | |||
| Net proceeds from initial public offering (“IPO”) | |||
| Proceeds from capital injection from investors | |||
| Proceeds from other borrowings | |||
| Payment for IPO costs | |||
| Advance to related parties | |||
| Advance from a director | |||
| Proceeds from issuance of convertible notes | |||
| Advance from directors | |||
| Repayments to directors | |||
| Cash provided by financing activities | |||
| Net change in cash, cash equivalents and cash segregated for regulatory purpose | |||
| Cash, cash equivalents and cash segregated for regulatory purpose at beginning of the year | |||
| Cash, cash equivalents and cash segregated for regulatory purpose at the end of the year | |||
| Supplementary cash flows information | |||
| Cash received from interest | |||
| Cash paid for income taxes | |||
| Supplemental schedule of non-cash investing and financing activities | |||
| Repayment of loans through issuance of shares | |||
| Acquisition of an associate through issuance of Class A Ordinary Shares | |||
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | |||
| Reconciliation to amounts on consolidated balance sheets: | |||
| Cash and cash equivalents | |||
| Cash segregated for regulatory purpose |
Loading...
